Competition in India's obesity drug market heats up as generic versions of popular weight-loss medications launch. Following patent expiry, multiple Indian drugmakers have released their versions. This move aims to increase accessibility in a price-sensitive…
With the patent expiry of Lilly and Novos weight-loss drugs in India on March 20, at least six generic drugmakers have already launched their versions, intensifying competition in the countrys obesit… [+2259 chars]
